KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Cash from Financing Activities (2016 - 2025)

Omega Healthcare Investors' Cash from Financing Activities history spans 14 years, with the latest figure at -$940.5 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 486.37% year-over-year to -$940.5 million; the TTM value through Dec 2025 reached -$838.3 million, down 3284.98%, while the annual FY2025 figure was -$838.3 million, 3284.98% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$940.5 million at Omega Healthcare Investors, down from -$139.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $589.0 million in Q2 2025 and bottomed at -$940.5 million in Q4 2025.
  • The 5-year median for Cash from Financing Activities is -$162.4 million (2021), against an average of -$120.8 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 740.91% in 2024 before it tumbled 486.37% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$166.1 million in 2021, then increased by 2.51% to -$162.0 million in 2022, then crashed by 140.65% to -$389.8 million in 2023, then skyrocketed by 162.45% to $243.4 million in 2024, then crashed by 486.37% to -$940.5 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Cash from Financing Activities are -$940.5 million (Q4 2025), -$139.0 million (Q3 2025), and $589.0 million (Q2 2025).